You are viewing the site in preview mode

Skip to content

Advertisement

Clinical Radiation Oncology

Section edited by Stephanie Combs, Pirus Ghadjar, Matthias Guckenberger, Daniel Habermehl, Silke Nachbichler, Maximilian Niyazi, and Falk Roeder

The Clinical Radiation Oncology section aims to provide a platform for clinical research in radiation oncology. Research includes innovative early phase and later stage clinical trials, technical approaches, review articles on “burning” clinical questions, invited key reviews, RT planning studies, multimodal therapy, data mining from retrospective cohorts in a hypothesis-generating manner, interconnection between imaging and improved target delineation, and intensity modulation/high precision techniques. The section addresses current, timely and cutting- edge research and reviews about clinically relevant issues in radiation oncology, while offering a fast review process.

Page 1 of 15

  1. Content type: Research

    Automatic multi-criteria optimization is necessary for intensity modulated radiation therapy (IMRT) because of low planning efficiency and large plan quality uncertainty in current clinical practice. Most stud...

    Authors: Yanhua Mai, Fantu Kong, Yiwei Yang, Linghong Zhou, Yongbao Li and Ting Song

    Citation: Radiation Oncology 2018 13:241

    Published on:

  2. Content type: Research

    Neoadjuvant radio- or chemoradiation (nIRT) therapy is the standard treatment for loco-regional advanced rectal cancer patients of the lower or middle third. Currently, intensity modulated radiation therapy (I...

    Authors: Hendrik Dapper, Iván Rodríguez, Stefan Münch, Jan C. Peeken, Kai Borm, Stephanie E. Combs and Daniel Habermehl

    Citation: Radiation Oncology 2018 13:237

    Published on:

  3. Content type: Research

    Peer review systems within radiation oncology are important to ensure quality radiation care. Several individualized methods for radiation oncology peer review have been described. However, despite the importa...

    Authors: Ashley A. Albert, William N. Duggar, Rahul P. Bhandari, Toms Vengaloor Thomas, Satyaseelan Packianathan, Robert M. Allbright, Madhava R. Kanakamedala, Divyang Mehta, Chunli Claus Yang and Srinivasan Vijayakumar

    Citation: Radiation Oncology 2018 13:239

    Published on:

  4. Content type: Research

    Volumetric shrinkage of normal tissues such as salivary glands, kidneys, hippocampus are observed after radiotherapy. We aimed to assess the alterations in pancreatic volume of patients who received abdominal ...

    Authors: Cengiz Gemici, Gokhan Yaprak, Sevim Ozdemir, Tamer Baysal, Ozgur Ozan Seseogullari and Hazan Ozyurt

    Citation: Radiation Oncology 2018 13:238

    Published on:

  5. Content type: Research

    To compare the clinical outcome in prostate cancer patients treated with radiotherapy using two forms of image guidance: bone-based (BB) or fiducial-based (FB).

    Authors: Aleksandra Napieralska, Wojciech Majewski, Roland Kulik, Grzegorz Głowacki and Leszek Miszczyk

    Citation: Radiation Oncology 2018 13:235

    Published on:

  6. Content type: Research

    The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective p...

    Authors: Marta Scorsetti, Tiziana Comito, Elena Clerici, Ciro Franzese, Angelo Tozzi, Cristina Iftode, Lucia Di Brina, Pierina Navarria, Pietro Mancosu, Giacomo Reggiori, Antonella Fogliata, Stefano Tomatis, Guido Torzilli and Luca Cozzi

    Citation: Radiation Oncology 2018 13:234

    Published on:

  7. Content type: Research

    The usefulness of particle therapy for skull base chordoma has not been established. The aim of this retrospective study was to analyse the treatment outcomes of proton therapy (PT) and carbon ion therapy (CIT...

    Authors: Masaru Takagi, Yusuke Demizu, Fumiko Nagano, Kazuki Terashima, Osamu Fujii, Dongcun Jin, Masayuki Mima, Yasue Niwa, Kuniaki Katsui, Masaki Suga, Tomohiro Yamashita, Takashi Akagi, Koh-ichi Sakata, Nobukazu Fuwa and Tomoaki Okimoto

    Citation: Radiation Oncology 2018 13:232

    Published on:

  8. Content type: Research

    Tangent-based intensity modulated radiation therapy (TIMRT) is a common adjuvant radiotherapy strategy for breast cancer patients. This study compared the dosimetric characteristics of tangent-based volumetric...

    Authors: Pei-Chieh Yu, Ching-Jung Wu, Yu-Lun Tsai, Suzun Shaw, Shih-Yu Sung, Louis Tak Lui and Hsin-Hua Nien

    Citation: Radiation Oncology 2018 13:231

    Published on:

  9. Content type: Research

    The purpose of this study is to compare the efficacy and safety of concurrent chemoradiotherapy (CCRT) versus chemotherapy alone for patients with stage IV esophageal squamous cell carcinoma (ESCC).

    Authors: Jiahua Lyu, Tao Li, Qifeng Wang, Fang Li, Peng Diao, Li Liu, Churong Li and Jinyi Lang

    Citation: Radiation Oncology 2018 13:233

    Published on:

  10. Content type: Research

    To evaluate the treatment outcome and prostate-specific antigen (PSA) change after stereotactic body radiotherapy (SBRT) for localized prostate cancer.

    Authors: Younghee Park, Hae Jin Park, Won Il Jang, Bae Kwon Jeong, Hun-Jung Kim and Ah Ram Chang

    Citation: Radiation Oncology 2018 13:230

    Published on:

  11. Content type: Research

    The ano-inguinal lymphatic drainage (AILD) is located in the subcutaneous adipose tissue of the proximal medial thigh. Currently, there are no recommendations for an inclusion of the ‘true’ AILD in the clinica...

    Authors: Hendrik Dapper, Markus Oechsner, Christoph Hirche, Stefan Münch, Christina Sauter, Kai Borm, Jan C. Peeken, Stephanie E. Combs and Daniel Habermehl

    Citation: Radiation Oncology 2018 13:227

    Published on:

  12. Content type: Research

    Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line ex...

    Authors: Tharcisio Machado Coelho, Ricardo César Fogaroli, Antonio Cassio Assis Pellizzon, Douglas Guedes De Castro, Guilherme Rocha Melo Gondim, Maria Leticia Gobo Silva, Michael Jenwei Chen and Henderson Ramos

    Citation: Radiation Oncology 2018 13:224

    Published on:

  13. Content type: Research

    Currently, the standard treatment for locally advanced cervical cancer patients is concurrent chemoradiotherapy. Here we aim to evaluate therapeutic efficacy, treatment failure, toxicity and prognostic factors...

    Authors: Qingyu Meng, Weiping Wang, Xiaoliang Liu, Xiaorong Hou, Xin Lian, Shuai Sun, Junfang Yan, Zhikai Liu, Zheng Miao, Ke Hu and Fuquan Zhang

    Citation: Radiation Oncology 2018 13:223

    Published on:

  14. Content type: Research

    It has been reported that proximity of the tumor to the optic disc and macula, and radiation dose to the critical structures are substantial risk factors for vision loss following plaque brachytherapy. However...

    Authors: Yongsook C. Lee, Shih-Chi Lin and Yongbok Kim

    Citation: Radiation Oncology 2018 13:221

    Published on:

  15. Content type: Research

    To propose an easily applicable segmentation method (perPET-RT) for delineation of tumour volume during radiotherapy on interim fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomogr...

    Authors: J. Ganem, S. Thureau, I. Gardin, R. Modzelewski, S. Hapdey and P. Vera

    Citation: Radiation Oncology 2018 13:219

    Published on:

  16. Content type: Research

    This study was performed to evaluate skin toxicity during modern three-dimensional conformal radiotherapy (3D-CRT) and to evaluate the importance of dose distribution and patient related factors.

    Authors: Kai J. Borm, Maximilian Loos, Markus Oechsner, Michael C. Mayinger, Daniela Paepke, Marion B. Kiechle, Stephanie E. Combs and Marciana N. Duma

    Citation: Radiation Oncology 2018 13:218

    Published on:

  17. Content type: Research

    Cancer cachexia is a prevalent symptom of head and neck neoplasms. The reduction in skeletal muscle mass is one of the main characteristics which can lead to poor physical functioning. The purposes of this pil...

    Authors: Manuel Grote, Cornelius Maihöfer, Martin Weigl, Patricia Davies-Knorr and Claus Belka

    Citation: Radiation Oncology 2018 13:215

    Published on:

  18. Content type: Research

    Dose escalation of conventionally fractionated radiation therapy (CFRT) above 45–54 Gy has an unclear survival benefit. Prior National Cancer Database (NCDB) analyses have shown improved overall survival with ...

    Authors: Sung Jun Ma, Kavitha M. Prezzano, Gregory M. Hermann and Anurag K. Singh

    Citation: Radiation Oncology 2018 13:214

    Published on:

  19. Content type: Research

    A high neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation and together with the platelet-to-lymphocyte ratio (PLR) is associated with worse outcomes in several solid tumors. We investiga...

    Authors: Beat Bojaxhiu, Arnoud J. Templeton, Olgun Elicin, Mohamed Shelan, Kathrin Zaugg, Marc Walser, Roland Giger, Daniel M. Aebersold and Alan Dal Pra

    Citation: Radiation Oncology 2018 13:216

    Published on:

  20. Content type: Research

    To determine the prognostic impact of comorbidity and age in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) using the age-adjusted Charls...

    Authors: Julia Dreyer, Michael Bremer and Christoph Henkenberens

    Citation: Radiation Oncology 2018 13:213

    Published on:

  21. Content type: Research

    This was a prespecified secondary analysis of a randomized trial that analyzed bone density and pain response following fractionated intensity-modulated radiotherapy (IMRT) versus three-dimensional conformal r...

    Authors: Tanja Sprave, Vivek Verma, Robert Förster, Ingmar Schlampp, Katharina Hees, Thomas Bruckner, Tilman Bostel, Rami Ateyah El Shafie, Thomas Welzel, Nils Henrik Nicolay, Jürgen Debus and Harald Rief

    Citation: Radiation Oncology 2018 13:212

    Published on:

  22. Content type: Research

    [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) may be used for tumor staging and prognosis in several tumors but its role in rectal cancer is still debated. The ai...

    Authors: Letizia Deantonio, Angela Caroli, Erinda Puta, Daniela Ferrante, Francesco Apicella, Lucia Turri, Gianmauro Sacchetti, Marco Brambilla and Marco Krengli

    Citation: Radiation Oncology 2018 13:211

    Published on:

  23. Content type: Research

    To evaluate long-term IPSS score and urinary quality of life after radiotherapy for prostate cancer, in patients with prior history of surgical treatment for benign prostatic hyperplasia (BPH).

    Authors: Mélanie Guilhen, Christophe Hennequin, Idir Ouzaid, Ingrid Fumagalli, Valentine Martin, Sophie Guillerm, Pierre Mongiat-Artus, Vincent Ravery, François Desgrandchamps and Laurent Quéro

    Citation: Radiation Oncology 2018 13:209

    Published on:

  24. Content type: Research

    The aim of our study was to evaluate feasibility, toxicity profile and local control of salvage intensity modulated radiotherapy (IMRT) delivered with simultaneous integrated boost (SIB) associated or not to c...

    Authors: L. Nicosia, L. Agolli, C. Reverberi, V. De Sanctis, L. Marinelli, G. Minniti, J. Di Muzio, M. Valeriani and M. F. Osti

    Citation: Radiation Oncology 2018 13:207

    Published on:

  25. Content type: Research

    To assess the efficacy and safety of stereotactic body radiation therapy (SBRT) in the management of adrenal gland metastases (AGMs) from lung cancer. Moreover, it is the first two-institutional experience and...

    Authors: Xianzhi Zhao, Xiaofei Zhu, Jianfeng Fei, Haipeng Ren, Yangsen Cao, Xiaoping Ju, Zhiyong Yuan and Huojun Zhang

    Citation: Radiation Oncology 2018 13:205

    Published on:

  26. Content type: Research

    Stereotactic ablative radiotherapy (SABR) offers an alternative treatment for pancreatic cancer, with the potential for improved tumour control and reduced toxicity compared with conventional therapies. Howeve...

    Authors: Christy Goldsmith, P. Nicholas Plowman, Melanie M. Green, Roger G. Dale and Patricia M. Price

    Citation: Radiation Oncology 2018 13:204

    Published on:

  27. Content type: Research

    Radiation-induced heart disease is mainly caused by activation of the fibrotic process. Transforming growth factor-beta 1 (TGF-β1) and platelet-derived growth factor (PDGF) are pro-fibrotic mediators. The aim ...

    Authors: Hanna Aula, Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen and Pirkko-Liisa Kellokumpu-Lehtinen

    Citation: Radiation Oncology 2018 13:201

    Published on:

  28. Content type: Research

    The prognostic value of supra-clavicular lymph node (SCLN) metastases in esophageal cancer (EC) is still not clear.

    Authors: Hong-Yao Xu, Sheng-Xi Wu, He-San Luo, Chu-Yun Chen, Lian-Xing Lin and He-Cheng Huang

    Citation: Radiation Oncology 2018 13:200

    Published on:

  29. Content type: Research

    Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung cancer (NSCLC). The...

    Authors: Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Toshiyuki Toshito, Kensuke Hayashi, Kenji Akita, Fumiya Baba, Katsumi Nakamae, Jun-etsu Mizoe and Yuta Shibamoto

    Citation: Radiation Oncology 2018 13:199

    Published on:

  30. Content type: Research

    To compare patterns of care for elderly patients versus non-elderly patients with non-surgically treated stage III non-small cell lung cancer (NSCLC) using the National Cancer Database (NCDB). We hypothesize t...

    Authors: Eric D Miller, James L Fisher, Karl E Haglund, John C Grecula, Meng Xu-Welliver, Erin M Bertino, Kai He, Peter G Shields, David P Carbone, Terence M Williams, Gregory A Otterson and Jose G Bazan

    Citation: Radiation Oncology 2018 13:196

    Published on:

  31. Content type: Research

    Adjuvant radiotherapy in advanced head and neck squamous cell cancer (HNSCC) reduces the risk of local-regional failure and most likely increases the survival rate. Patients at high risk for tumor recurrence m...

    Authors: Christiane Matuschek, Jan Haussmann, Edwin Bölke, Stephan Gripp, Patrick J. Schuler, Bálint Tamaskovics, Peter Arne Gerber, Freddy-Joel Djiepmo-Njanang, Kai Kammers, Christian Plettenberg, Bahar Anooshahr, Klaus Orth and Wilfried Budach

    Citation: Radiation Oncology 2018 13:195

    Published on:

  32. Content type: Research

    Radiation therapy is the standard radical treatment for nasopharyngeal carcinoma (NPC) but also causes transient as well as long-term complications. Patients who develop severe radiation-induced brainstem inju...

    Authors: Cheng-Yun Yao, Guo-Ren Zhou, Li-Jun Wang, Jian-Hua Xu, Jin-jun Ye, Lan-Fang Zhang, Xia He, Zhen-Zhang Chen and Sheng-Fu Huang

    Citation: Radiation Oncology 2018 13:194

    Published on:

  33. Content type: Research

    The SpaceOAR hydrogel is employed to limit rectal radiation dose during prostate radiotherapy. We identified a novel parameter – the product of angle θ and hydrogel volume – to quantify hydrogel placement. Thi...

    Authors: Mark E Hwang, Paul J Black, Carl D Elliston, Brian A Wolthuis, Deborah R Smith, Cheng-Chia Wu, Sven Wenske and Israel Deutsch

    Citation: Radiation Oncology 2018 13:192

    Published on:

  34. Content type: Research

    There is currently no worldwide consensus for the management of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). We evaluated the efficacy of stereotactic body radiotherapy (SBRT) as the ...

    Authors: Yongjie Shui, Wei Yu, Xiaoqiu Ren, Yinglu Guo, Jing Xu, Tao Ma, Bicheng Zhang, Jianjun Wu, Qinghai Li, Qiongge Hu, Li Shen, Xueli Bai, Tingbo Liang and Qichun Wei

    Citation: Radiation Oncology 2018 13:188

    Published on:

  35. Content type: Research

    Physicians and physicists are expected to contribute to patient safety and quality improvement (QI) in Radiation Oncology (RO), but prior studies suggest that training for this may be inadequate. RO and medica...

    Authors: Matthew B. Spraker, Matthew J. Nyflot, Kristi R. G. Hendrickson, Stephanie Terezakis, Shannon E. Fogh, Gabrielle M. Kane, Eric C. Ford and Jing Zeng

    Citation: Radiation Oncology 2018 13:186

    Published on:

  36. Content type: Research

    The patterns of nodal relapse in submandibular gland carcinoma (SMGC) patients treated with postoperative radiotherapy (PORT) remain unclear. This study aims to investigate the nodal failure patterns and the u...

    Authors: Cheng-En Hsieh, Li-Yu Lee, Yung-Chih Chou, Kang-Hsing Fan, Ngan-Ming Tsang, Joseph Tung-Chieh Chang, Hung-Ming Wang, Shu-Hang Ng, Chun-Ta Liao, Tzu-Chen Yen, Ku-Hao Fang and Chien-Yu Lin

    Citation: Radiation Oncology 2018 13:184

    Published on:

  37. Content type: Research

    Prostate cancer (PCA) is the most-prevalent non-skin cancer in men worldwide. Nevertheless, the treatment of oligometastatic, especially lymph-node (ln) recurrent, PCA remains elusive. The aim of our study was...

    Authors: M. Oertel, S. Scobioala, K. Kroeger, A. Baehr, L. Stegger, U. Haverkamp, M. Schäfers and H.-T. Eich

    Citation: Radiation Oncology 2018 13:185

    Published on:

  38. Content type: Research

    Concurrent chemoradiotherapy is considered curative intent treatment for patients with non-operative esophageal cancer. Radiation-induced heart damage receives much attention. We performed repeated four-dimens...

    Authors: Xue Wang, Jin-Zhi Wang, Jian-Bin Li, Ying-Jie Zhang, Feng-Xiang Li, Wei Wang, Yan-Luan Guo, Qian Shao, Min Xu, Xi-Jun Liu and Yue Wang

    Citation: Radiation Oncology 2018 13:181

    Published on:

  39. Content type: Research

    This study evaluated the effect of radiation dose rate in patients with hematolymphoid malignancies undergoing myeloablative conditioning with total body irradiation (TBI), for hematopoietic stem cell transpla...

    Authors: Dong-Yun Kim, Il Han Kim, Sung-Soo Yoon, Hyoung Jin Kang, Hee Young Shin and Hyun-Cheol Kang

    Citation: Radiation Oncology 2018 13:180

    Published on:

  40. Content type: Research

    We report prospectively captured clinical toxicity and patient reported outcomes in a single institutional cohort of patients treated for prostate cancer with proton beam therapy (PBT). This is the largest rep...

    Authors: Howard J. Lee Jr, Meghan W. Macomber, Matthew B. Spraker, Stephen R. Bowen, Daniel S. Hippe, Angela Fung, Kenneth J. Russell, George E. Laramore, Ramesh Rengan, Jay Liao, Smith Apisarnthanarax and Jing Zeng

    Citation: Radiation Oncology 2018 13:179

    Published on:

  41. Content type: Research

    To compare the efficacies and toxicities of intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy (3D-CRT) or conventional two-dimensional radiotherapy (2D-RT) for definitive tr...

    Authors: Yanzhu Lin, Kai Chen, Zhiyuan Lu, Lei Zhao, Yalan Tao, Yi Ouyang and Xinping Cao

    Citation: Radiation Oncology 2018 13:177

    Published on:

  42. Content type: Research

    To analyze the clinical outcome of elderly women with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interstitial hig...

    Authors: Rémy Kinj, Marie-Eve Chand, Jocelyn Gal, Mathieu Gautier, Lucile Montagné, Daniel Lam Cham Kee and Jean Michel Hannoun-Lévi

    Citation: Radiation Oncology 2018 13:174

    Published on:

  43. Content type: Research

    To evaluate clinical outcomes of simultaneous integrated boost (SIB) - intensity modulated radiotherapy (RT) in patients with non metastatic anal cancer compared to those of a set of patients treated with 3-di...

    Authors: Pierfrancesco Franco, Berardino De Bari, Francesca Arcadipane, Alexis Lepinoy, Manuela Ceccarelli, Gabriella Furfaro, Massimiliano Mistrangelo, Paola Cassoni, Martina Valgiusti, Alessandro Passardi, Andrea Casadei Gardini, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Andrea Evangelista, Umberto Ricardi…

    Citation: Radiation Oncology 2018 13:172

    Published on:

  44. Content type: Research

    To investigate the treatment failure pattern and factors influencing locoregional recurrence of esophageal squamous cell carcinoma (ESCC) and examine patient survival with re-irradiation (re-RT) after primary ...

    Authors: Liang Hong, Yun-xia Huang, Qing-yang Zhuang, Xue-qing Zhang, Li-rui Tang, Kai-xin Du, Xiao-yi Lin, Bu-hong Zheng, Shao-li Cai, Jun-xin Wu and Jin-luan Li

    Citation: Radiation Oncology 2018 13:171

    Published on:

  45. Content type: Research

    The cranial border of the target volume (TV) in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT) is mostly defined at the level of L5/S1. However, current studies have shown that relapse c...

    Authors: Hendrik Dapper, Markus Oechsner, Stefan Münch, Kai Borm, Jan Peeken, Michael Mayinger, Stephanie E. Combs and Daniel Habermehl

    Citation: Radiation Oncology 2018 13:169

    Published on:

  46. Content type: Case report

    Histiocytic sarcoma (HS) is an aggressive malignant neoplasm. HS in the central nervous system is exceptionally rare and associated with a poor prognosis. This report documents a case of primary HS of the cent...

    Authors: Jackson M. May, Mark R. Waddle, Daniel H. Miller, William C. Stross, Tasneem A. Kaleem, Byron C. May, Robert C. Miller, Liuyan Jiang, Gerald W. Strong, Daniel M. Trifiletti, Kaisorn L. Chaichana, Ronald Reimer, Han W. Tun and Jennifer L. Peterson

    Citation: Radiation Oncology 2018 13:167

    Published on:

  47. Content type: Study protocol

    Stereotactic body radiotherapy (SBRT) is an emerging treatment alternative for patients with localized prostate cancer. Promising results in terms of disease control and toxicity have been reported with 4 to 5...

    Authors: Thomas Zilli, Marta Scorsetti, Daniel Zwahlen, Ciro Franzese, Robert Förster, Niccolò Giaj-Levra, Nikolaos Koutsouvelis, Aurelie Bertaut, Michel Zimmermann, Giuseppe Roberto D’Agostino, Filippo Alongi, Matthias Guckenberger and Raymond Miralbell

    Citation: Radiation Oncology 2018 13:166

    Published on:

    The Correction to this article has been published in Radiation Oncology 2018 13:182

  48. Content type: Research

    Although patients experience radiation proctitis post radiotherapy no internationally tested instruments exist to measure these symptoms. This Phase IV study tested the scale structure, reliability and validit...

    Authors: Georgia K. B. Halkett, Charles Adam Wigley, Samar M Aoun, Maurizio Portaluri, Francesco Tramacere, Lorenzo Livi, Beatrice Detti, Stefano Arcangeli, Jo-Asmund Lund, Are Kristensen, Nathalie McFadden, Arne Grun, Sean Bydder, Irina Sackerer, Elfriede Greimel and Nigel Spry

    Citation: Radiation Oncology 2018 13:162

    Published on:

  49. Content type: Short report

    The reporting of adverse effects is an integral aspect of a hospital quality improvement (QI) program with the goal of improving care for current and future patients. We report the results of our experience tr...

    Authors: Varun Chowdhry, Pamela Jangro, Saveli Goldberg, Nolan Gagne, Shelley Chabot, Gary Proulx and Cocav Rauwerdink

    Citation: Radiation Oncology 2018 13:161

    Published on:

2017 Journal Metrics

Advertisement